Among these transporters, according to [33], ABCB4 significantly correlates with the CD133 stem cell marker expression and poor OS in GBM patients with the CD133 + GSCs, contributing to TMZ-resistance by exhibiting reduced responsiveness to TMZ, compared to CD133 − GSCs. Here, PROM1 is linked to glioblastoma.